Using human genetics to improve safety assessment of therapeutics
Keren Carss(AstraZeneca (United Kingdom)), Aimée M. Deaton(Amgen (United States)), Alberto Del Río-Espínola(Novartis (Switzerland)), Dorothée Diogo(Takeda (United States)), Mark R. Fielden(Amgen (United States)), Diptee Kulkarni(GlaxoSmithKline (United States)), Jonathan G. Moggs(Novartis (Switzerland)), Peter Newham(AstraZeneca (United Kingdom)), Matthew R. Nelson(Deerfield (United States)), Frank D. Sistare(United States Military Academy), Lucas D. Ward(Amgen (United States)), Jing Yuan(Amgen (United States))
Cited by 85
Abstract
Related Papers
No related papers found
Powered by citation graph analysis